Cautious interpretation of antiphospholipid antibodies in COVID-19.

作者信息

Mehta Sudhir, Bhandari Sudhir, Mehta Shaurya

机构信息

Depatment of Medicine, SMS Medical College (University Medical School), Jaipur, India.

出版信息

Clin Chim Acta. 2020 Oct;509:166. doi: 10.1016/j.cca.2020.06.024. Epub 2020 Jun 15.

DOI:10.1016/j.cca.2020.06.024

PMID:32553721

原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7836210/

Abstract

摘要

相似文献

[1]

Cautious interpretation of antiphospholipid antibodies in COVID-19.

Clin Chim Acta. 2020-10

[2]

Are antiphospholipid antibodies associated with thrombotic complications in critically ill COVID-19 patients?

Thromb Res. 2020-7-8

[3]

Researchers Home in on COVID-19 Severity Biomarkers.

JAMA. 2020-7-14

[4]

Interleukin-6 as a potential biomarker of COVID-19 progression.

Med Mal Infect. 2020-6

[5]

Emerging key laboratory tests for patients with COVID-19.

Clin Biochem. 2020-7

[6]

Lancet Diabetes Endocrinol. 2020-9

[7]

Eosinopenia could be a relevant prognostic biomarker in patients with coronavirus disease 2019.

Allergy Asthma Proc. 2020-11-1

[8]

Two consecutive myocardial tissue insults for inpatients with COVID-19.

Crit Care. 2020-5-26

[9]

Covid-19 antibody tests: a briefing.

BMJ. 2020-6-24

[10]

Profile of natural anticoagulant, coagulant factor and anti-phospholipid antibody in critically ill COVID-19 patients.

J Thromb Thrombolysis. 2020-10

引用本文的文献

[1]

NETosis and SARS-COV-2 infection related thrombosis: a narrative review.

Thromb J. 2022-3-30

[2]

COVID-19, Antiphospholipid Antibodies, and Catastrophic Antiphospholipid Syndrome: A Possible Association?

Clin Med Insights Arthritis Musculoskelet Disord. 2020-12-3

[3]

Immune Thrombocytopenia Secondary to COVID-19: a Systematic Review.

SN Compr Clin Med. 2020

[4]

Brain autopsies in fatal COVID-19 and postulated pathophysiology: more puzzling than a Rubik's cube.

J Clin Pathol. 2021-9

[5]

Thrombosis in Coronavirus disease 2019 (COVID-19) through the prism of Virchow's triad.

Clin Rheumatol. 2020-7-11

本文引用的文献

[1]

Lupus Anticoagulant and Abnormal Coagulation Tests in Patients with Covid-19.

N Engl J Med. 2020-7-16

[2]

High risk of thrombosis in patients with severe SARS-CoV-2 infection: a multicenter prospective cohort study.

Intensive Care Med. 2020-5-4

[3]

Lupus anticoagulant is frequent in patients with Covid-19.

J Thromb Haemost. 2020-8

[4]

Coagulopathy and Antiphospholipid Antibodies in Patients with Covid-19.

N Engl J Med. 2020-4-8

[5]

Lupus Anticoagulant (LAC) testing in patients with inflammatory status: does C-reactive protein interfere with LAC test results?

Thromb Res. 2010-1

[6]

Update of the guidelines for lupus anticoagulant detection. Subcommittee on Lupus Anticoagulant/Antiphospholipid Antibody of the Scientific and Standardisation Committee of the International Society on Thrombosis and Haemostasis.

J Thromb Haemost. 2009-7-17

[7]

Towards definition, clinical and laboratory criteria, and a scoring system for disseminated intravascular coagulation.

Thromb Haemost. 2001-11

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

新学期，新优惠

Cautious interpretation of antiphospholipid antibodies in COVID-19.

作者信息

机构信息

出版信息

相似文献

引用本文的文献

本文引用的文献

文献AI研究员

用中文搜PubMed

推荐工具

Suppr 超能文献

相似文献

引用本文的文献

本文引用的文献